Experts Available to Discuss Drugs with Potential to Slow Alzheimer's Progression.TOPIC: Drugs that could potentially slow the progression of memory loss were discussed during the ninth International Conference on Alzheimer's Disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. and Related Disorders, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. an article by USA TODAY. Tests for a vaccine that destroys beta amyloid amyloid /am·y·loid/ (am´i-loid) 1. starchlike; amylaceous. 2. the pathologic, extracellular, waxy, amorphous substance deposited in amyloidosis, being composed of fibrils in bundles or in a meshwork of polypeptide , which is a protein that develops into harmful brain deposits, showed promising results two years ago. Fifty-nine out of 300 people who received the vaccine developed antibodies that broke down the deposits. However, the testing was stopped as 18 people developed brain inflammations that were potentially life threatening. Another drug, Alzhemed was developed to prevent the brain deposits from forming in the first place. A study of 58 people with mild Alzheimer's showed progression of the disease slowed down in 10 people who received the drug. EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story: Dr. Roger G. Stoll is chairman, president, and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cortex Pharmaceuticals. Dr. Stoll has over 30 years of experience in the pharmaceutical, medical devices, and diagnostic industries. He can share his expertise regarding new drugs to treat memory loss, including mild cognitive impairment mild cognitive impairment (MCI), n memory loss generally associated with aging; does not affect normal independent functioning of an individual. and Alzheimer's disease. In addition to the Cortex board, Dr. Stoll currently serves as a member of the boards of directors of Agensys, Inc., Questcor Pharmaceuticals, Inc., and LifePoint, Inc. Dr. Sid Gilman, of the University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. , Department of Neurology, is a clinical neurologist and investigator and the Principal Investigator of the Michigan Alzheimer's Disease Research Center, one of about 27 centers funded for research and clinical care of persons with Alzheimer's disease and related dementia. The funding agency is the National Institute on Aging The National Institute on Aging is a division of the U.S. National Institutes of Health, located in Bethesda, Maryland. Formed in 1974, NIA's mission is to improve the health and well-being of older Americans through research. It is the primary U.S. , a branch of the National Institutes of Health. Professor Barry Oken, of the Oregon Health Sciences University, is a neurologist and research clinical neuroscientist at a major medical university. His main research, which has been funded by NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. , focuses on changes in alertness and attention associated with aging or central nervous system active drugs that affect modulatory systems. His areas of expertise include neurology, clinical neurophysiology and Alzheimer's disease. ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue. Journalists seeking to interview any of these experts can obtain contact information by visiting http://www.businesswire.com/. ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at the above web address. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion